tiprankstipranks
Trending News
More News >
Pharma Mar SA (PHMMF)
OTHER OTC:PHMMF
US Market

Pharma Mar SA (PHMMF) Income Statement

Compare
57 Followers

Pharma Mar SA Income Statement

Last quarter (Q4 2025), Pharma Mar SA's total revenue was €90.48M, an increase of 87.08% from the same quarter last year. In Q4, Pharma Mar SA's net income was €59.66M. See Pharma Mar SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 221.39M€ 174.85M€ 158.15M€ 196.34M€ 229.83M
Gross Profit
€ 209.13M€ 166.67M€ 148.54M€ 182.70M€ 213.39M
Operating Expenses
€ 168.85M€ 160.20M€ 152.37M€ 138.27M€ 121.04M
Depreciation and Amortization
€ 8.02M€ 6.77M€ 5.76M€ 5.90M€ 5.58M
EBITDA
€ 48.30M€ 21.23M€ 4.55M€ 52.07M€ 104.08M
Operating Income
€ 40.28M€ 6.47M€ -3.83M€ 44.07M€ 92.45M
Other Income/Expenses
€ 19.38M€ 5.52M€ 204.00K€ -281.00K€ -6.36M
Pretax Income
€ 59.65M€ 11.98M€ -3.62M€ 43.79M€ 95.13M
Net Income
€ 74.99M€ 26.13M€ 1.14M€ 49.36M€ 92.86M
Per Share Metrics
Basic EPS
€ 4.36€ 1.48€ 0.06€ 2.73€ 5.14
Diluted EPS
€ 4.36€ 1.48€ 0.06€ 2.73€ 5.13
Weighted Average Shares Outstanding
17.21M 17.54M 17.90M 18.05M 18.07M
Weighted Average Shares Outstanding (Diluted)
17.21M 17.56M 17.92M 18.06M 18.09M
Currency in EUR

Pharma Mar SA Earnings and Revenue History